Nitric oxide-induced genotoxicity, mitochondrial damage, and apoptosis in human lymphoblastoid cells expressing

Chun-Qi Li1, Laura J Trudel, Gerald N Wogan

  • 1Biological Engineering Division and Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Insights

Nitric oxide (NO) induces mutations and apoptosis. The p53 protein

Area of Science:

  • Cellular and Molecular Biology
  • Toxicology
  • Cancer Research

Background:

  • Nitric oxide (NO) is a signaling molecule with known mutagenic and apoptotic effects.
  • The precise mechanisms by which NO induces apoptosis, particularly involving the p53 protein and mitochondria, are not fully elucidated.
  • Understanding these pathways is crucial for comprehending cellular responses to NO in inflammatory conditions.

Purpose of the Study:

  • To investigate the role of p53 status in modulating NO-induced mutagenesis and apoptosis in human lymphoblastoid cells.
  • To elucidate the specific cellular and biochemical pathways affected by NO in a p53-dependent manner.
  • To compare the effects of NO on DNA damage, gene mutation, and apoptosis in cells with wild-type versus mutant p53.

Main Methods:

  • Exposure of human lymphoblastoid TK6 (wild-type p53) and WTK-1 (mutant p53) cells to NO via Silastic tubing at controlled rates.
  • Assessment of DNA double-strand breaks and fragmentation.
  • Quantification of gene mutations in HPRT and TK1 genes.
  • Analysis of apoptosis, mitochondrial membrane potential, cytochrome c release, and levels of Apaf-1 and XIAP proteins.

Main Results:

  • NO induced more extensive DNA damage in wild-type p53 cells (TK6) than in mutant p53 cells (WTK-1).
  • Mutagenesis was significantly lower in wild-type p53 cells compared to mutant p53 cells.
  • Apoptosis was pronounced in wild-type p53 cells but reduced and delayed in mutant p53 cells.
  • Mitochondrial depolarization and cytochrome c release occurred in both cell types, but Apaf-1 elevation and XIAP reduction were specific to wild-type p53 cells.

Conclusions:

  • p53 status is a critical regulator of NO-induced mutagenesis and apoptosis.
  • p53 influences NO-induced apoptosis through pathways involving Apaf-1 and XIAP protein levels, not solely mitochondrial events.
  • These findings highlight the importance of Apaf-1 and XIAP in p53-mediated apoptotic responses to NO.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair01:46

Nucleotide Excision Repair

Exposure to mutagens can damage DNA and result in bulky lesions that distort the double-helix structure or impede proper transcription. Damaged DNA can be detected and repaired in a process called nucleotide excision repair (NER). NER employs a set of specialized proteins that first scan DNA to detect a damaged region. Next, NER proteins separate the strands and excise the damaged area. Finally, they coordinate the replacement with new, matching nucleotides.DNA distortion and damageCells are...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...